Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

(2014) Wai-Kay Seto et al.   GUT

761 COMPARISON OF SERUM HBsAg DECLINES DURING TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN DIFFERENT CHRONIC HEPATITIS B (CHB) SUB-POPULATIONS

(2013) H.L. Chan et al.   JOURNAL OF HEPATOLOGY

756 SERUM HBsAg DECLINE IS FASTER THAN PREVIOUSLY ESTIMATED IN LONG-TERM NUC RESPONDERS WITH LOW TREATMENT-INDUCED HBsAg LEVELS

(2013) G. Mangia et al.   JOURNAL OF HEPATOLOGY

Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy

(2013) George Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?

(2013) George V. Papatheodoridis   LIVER INTERNATIONAL

Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir

(2012) Stephanos J. Hadziyannis et al.   GASTROENTEROLOGY

504 EARLY ON-TREATMENT DECLINE OF SERUM HEPATITIS B SURFACE ANTIGEN (HBSAG) IS ASSOCIATED WITH FASTER SUBSEQUENT HBSAG REDUCTION IN HBEAG-NEGATIVE CHRONIC HEPATITIS B

(2012) H.L.Y. Chan et al.   JOURNAL OF HEPATOLOGY

486 QUANTIFICATION OF HEPATITIS B SURFACE ANTIGEN AS A PREDICTOR OF OFF-TREATMENT SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ORAL NUCLEOS(T)IDE ANALOGUE

(2012) S.J. Suh et al.   JOURNAL OF HEPATOLOGY

Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely

(2012) Stéphane Chevaliez et al.   JOURNAL OF HEPATOLOGY

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D

(2012) Lucio Boglione et al.   LIVER INTERNATIONAL

Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections

(2012) Elham Mohit et al.   MOLECULAR IMMUNOLOGY

Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment

(2011) James Fung et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues

(2011) Jerzy Jaroszewicz et al.   ANTIVIRAL THERAPY

Hepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice

(2011) Marc Lütgehetmann et al.   GASTROENTEROLOGY

Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report

(2011) Henry Lik-Yuen Chan et al.   JOURNAL OF HEPATOLOGY

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

(2011) Roeland Zoutendijk et al.   JOURNAL OF INFECTIOUS DISEASES

Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir

(2010) Jurriën G.P. Reijnders et al.   JOURNAL OF HEPATOLOGY

Molecular epidemiology of chronic hepatitis B virus infection in Greece

(2010) Fylaktou Asimina et al.   JOURNAL OF MEDICAL VIROLOGY

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma☆

(2009) Anne-Marie Mohty et al.   IMMUNOBIOLOGY

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

(2008) Maurizia Rossana Brunetto et al.   HEPATOLOGY

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection

(2007) George V Papatheodoridis et al.   LANCET INFECTIOUS DISEASES